AU6284896A - Obesity protein intermediates and their preparation and use - Google Patents

Obesity protein intermediates and their preparation and use

Info

Publication number
AU6284896A
AU6284896A AU62848/96A AU6284896A AU6284896A AU 6284896 A AU6284896 A AU 6284896A AU 62848/96 A AU62848/96 A AU 62848/96A AU 6284896 A AU6284896 A AU 6284896A AU 6284896 A AU6284896 A AU 6284896A
Authority
AU
Australia
Prior art keywords
preparation
obesity protein
protein intermediates
intermediates
obesity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62848/96A
Other languages
English (en)
Inventor
John Edward Hale
Warren Cameron Mackellar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU6284896A publication Critical patent/AU6284896A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Obesity (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Child & Adolescent Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU62848/96A 1995-06-22 1996-06-20 Obesity protein intermediates and their preparation and use Abandoned AU6284896A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45195P 1995-06-22 1995-06-22
US000451 1995-06-22
PCT/US1996/010613 WO1997000886A1 (fr) 1995-06-22 1996-06-20 Intermediaires de proteines contre l'obesite, leur preparation et leur utilisation

Publications (1)

Publication Number Publication Date
AU6284896A true AU6284896A (en) 1997-01-22

Family

ID=21691591

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62848/96A Abandoned AU6284896A (en) 1995-06-22 1996-06-20 Obesity protein intermediates and their preparation and use

Country Status (5)

Country Link
EP (1) EP0833835A4 (fr)
JP (1) JPH11508134A (fr)
AU (1) AU6284896A (fr)
CA (1) CA2224867A1 (fr)
WO (1) WO1997000886A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2217698A1 (fr) * 1996-12-20 1998-06-20 Eli Lilly And Company Proteines contre l'obesite
US6420339B1 (en) 1998-10-14 2002-07-16 Amgen Inc. Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility
DE10059336A1 (de) * 2000-11-29 2002-06-13 Scil Proteins Gmbh Herstellung von rekombinantem BMP-2
ATE475094T1 (de) 2001-10-22 2010-08-15 Amgen Inc Verwendung von leptin zur behandlung von lipoatrophie im menschen und verfahren zur bestimmmung einer prädisposition gegenüber der behandlung
EP2416797A4 (fr) 2009-04-10 2013-04-24 Amylin Pharmaceuticals Llc Composés agonistes de l'amyline pour mammifères ayant une carence en strogènes
MX351128B (es) 2010-09-28 2017-10-03 Aegerion Pharmaceuticals Inc Polipeptidos manipulados que tienen duracion de accion incrementada.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE241642T1 (de) * 1993-02-04 2003-06-15 Denzyme Aps Verbessertes verfahren zur rückfaltung der proteine
US6309853B1 (en) * 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
US5594101A (en) * 1995-03-03 1997-01-14 Eli Lilly And Company Anti-obesity proteins
GB9509164D0 (en) * 1995-05-05 1995-06-28 Smithkline Beecham Plc Novel compounds
ES2216055T3 (es) * 1995-08-17 2004-10-16 Amgen Inc Metodos para reducir o mantener niveles reducidos de lipidos en sangre usando composiciones de proteina ob.

Also Published As

Publication number Publication date
CA2224867A1 (fr) 1997-01-09
WO1997000886A1 (fr) 1997-01-09
JPH11508134A (ja) 1999-07-21
EP0833835A4 (fr) 1999-05-26
EP0833835A1 (fr) 1998-04-08

Similar Documents

Publication Publication Date Title
IL118469A (en) Naphthalene derivatives their preparation and intermediates thereof
AU5721798A (en) Human mage-like protein
AU6030398A (en) Human proteins
AU6124196A (en) Novel dolastatin derivatives, their preparation and use
AU5093796A (en) Human transcription factors and binding assays
AU6288296A (en) Novel human chemotactic cytokine
AU3804995A (en) Melanoma-associated protein
AU4750097A (en) Human reg i-gamma protein
AU4480697A (en) Human nm23-like protein
AU1538497A (en) Anti-gp46 antibodies and fragments thereof and their use
AU4862396A (en) Human obesity gene
ZA96240B (en) Novel peptides their preparation and use
AU1750997A (en) Obesity protein formulations
AU2408397A (en) Ob protein receptor genes and use of the same
AU2438695A (en) Therapeutic phenoxyalkylpyridazines and intermediates therefor
AU6284896A (en) Obesity protein intermediates and their preparation and use
AU9017598A (en) Human frezzled-like protein
AU1705197A (en) Obesity protein formulations
AU5613498A (en) Cerebellum and embryo specific protein
AU5369396A (en) Rest protein and dna
AU7520396A (en) Abl-interactor protein
AU2243997A (en) Obesity protein formulations
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
AU4459196A (en) Sustained-release preparation and use
ZA96239B (en) Novel peptides their preparation and use